EP Wealth Advisors LLC Takes Position in Mettler-Toledo International Inc. (NYSE:MTD)

EP Wealth Advisors LLC bought a new position in shares of Mettler-Toledo International Inc. (NYSE:MTD) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 149 shares of the medical instruments supplier’s stock, valued at approximately $223,000.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Kovitz Investment Group Partners LLC boosted its stake in Mettler-Toledo International by 64.1% during the third quarter. Kovitz Investment Group Partners LLC now owns 704 shares of the medical instruments supplier’s stock valued at $1,056,000 after buying an additional 275 shares in the last quarter. Wellington Management Group LLP boosted its position in shares of Mettler-Toledo International by 17.5% during the 3rd quarter. Wellington Management Group LLP now owns 177,963 shares of the medical instruments supplier’s stock valued at $266,891,000 after purchasing an additional 26,443 shares in the last quarter. State Street Corp grew its stake in shares of Mettler-Toledo International by 1.0% in the 3rd quarter. State Street Corp now owns 954,653 shares of the medical instruments supplier’s stock worth $1,431,693,000 after purchasing an additional 9,009 shares during the last quarter. Quantinno Capital Management LP raised its holdings in shares of Mettler-Toledo International by 17.8% in the 3rd quarter. Quantinno Capital Management LP now owns 5,524 shares of the medical instruments supplier’s stock worth $8,285,000 after purchasing an additional 836 shares in the last quarter. Finally, Royal London Asset Management Ltd. lifted its stake in Mettler-Toledo International by 0.9% during the third quarter. Royal London Asset Management Ltd. now owns 32,729 shares of the medical instruments supplier’s stock valued at $49,084,000 after purchasing an additional 277 shares during the last quarter. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the stock. Evercore ISI lifted their price target on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 1st. Wolfe Research started coverage on Mettler-Toledo International in a report on Friday. They issued a “peer perform” rating on the stock. Robert W. Baird reduced their target price on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a report on Monday, November 11th. Wells Fargo & Company dropped their price target on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a research note on Monday, November 11th. Finally, Stifel Nicolaus reduced their price objective on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research note on Monday, November 11th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $1,351.25.

Mettler-Toledo International Trading Up 0.0 %

NYSE MTD opened at $1,276.98 on Friday. Mettler-Toledo International Inc. has a 1-year low of $1,115.64 and a 1-year high of $1,546.93. The firm’s fifty day simple moving average is $1,305.85 and its 200-day simple moving average is $1,376.86. The company has a market capitalization of $26.95 billion, a PE ratio of 34.43, a price-to-earnings-growth ratio of 4.19 and a beta of 1.13.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, topping analysts’ consensus estimates of $10.00 by $0.21. The company had revenue of $954.54 million during the quarter, compared to the consensus estimate of $941.93 million. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. As a group, analysts predict that Mettler-Toledo International Inc. will post 40.42 EPS for the current year.

Insiders Place Their Bets

In other news, insider Gerry Keller sold 140 shares of the company’s stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $1,254.09, for a total transaction of $175,572.60. Following the completion of the sale, the insider now owns 6 shares in the company, valued at approximately $7,524.54. This represents a 95.89 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Elisha W. Finney sold 76 shares of the firm’s stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total value of $99,693.00. Following the completion of the transaction, the director now directly owns 240 shares in the company, valued at $314,820. The trade was a 24.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.94% of the company’s stock.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.